---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "eKs1lIN9radqbHwZYMVKXOh30WL9kCMM6O7bNGVrZcYTMJSqy8UaYJMAWFjhtJylR1MqrwwZkfbkdzFrWdDzHi6l+bA4NNphMrM16OJpYvt8BKOwPhiUUmv1ozbHWWSPjCi/RbIBtV+uDQOpx16+v0+bgQsM5HFilw6DUSFF6s8bzoUmH2AiOaSZcZRKQvLMB8U9T7vTZB+ZSs3fX8NzrFOLzboHAZfAq6hpz2G04uFnypRi8unTYF5gu4YD8L44SX9kn58536UYEgcBfVMdD4yoB5yDXd+DWqKZ3MwDF33oHrNcxZDQRfZewWQBf8fa;9FDScGm+07lqB+aSyPZc2w=="
---

